Imipramine for refractory daytime incontinence in the pediatric population
Lower urinary tract (LUT) and voiding dysfunction constitute a large percentage of pediatric urology referrals. Children with urinary incontinence unresponsive to behavioral modifications and traditional pharmacotherapy including anticholinergics and alpha blockers remain a challenge. We evaluated the impact of imipramine on treatment outcomes in children with refractory incontinence.
Source: Journal of Pediatric Urology - Category: Urology & Nephrology Authors: Israel Franco, Angela M. Arlen, Therese Collett-Gardere, Paul F. Zelkovic Source Type: research
More News: Children | Imipramine | Incontinence | Israel Health | Middle East Health | Pediatrics | Urology & Nephrology